Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Baker Bros. Advisors Lp
Form 13F · Q2 2026

Baker Bros. Advisors Lp

CIK 1263508申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$199.6亿
申報組合市值
84
持倉數量
12
Quarters on record
Top 50
持倉數量

Baker Bros. Advisors Lp——持倉

共 84 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1INCY Incyte Corp30.8M+0.1%$34.9亿17.5%
2ONC Beone Medicines Ltd8.8M+0.0%$25.1亿12.6%
3RVMD Revolution Medicines Inc11.4M+19.8%$21.4亿10.7%
4MDGL Madrigal Pharmaceuticals Inc2.1M+0.1%$11.5亿5.8%
5ACAD Acadia Pharmaceuticals Inc42.9M+0.0%$10.9亿5.4%
6KYMR Kymera Therapeutics Inc8.7M+0.0%$9.9亿5.0%
7INSM Insmed Inc8.8M+18.5%$9.4亿4.7%
8CELC Celcuity Inc7.9M+0.0%$8.3亿4.2%
9KOD Kodiak Sciences Inc19.9M+0.0%$7.8亿3.9%
10RYTM Rhythm Pharmaceuticals Inc5.6M+0.0%$6.2亿3.1%
11PRAX Praxis Precision Medicines I1.8M+0.0%$5.9亿2.9%
12ALKS Alkermes Plc10.0M+0.0%$5.2亿2.6%
13SMMT Summit Therapeutics Inc32.8M−9.9%$4.8亿2.4%
14GRAL Grail Inc4.0M+0.0%$2.8亿1.4%
15ABCL Abcellera Biologics Inc33.0M+9.0%$2.6亿1.3%
16IMVT Immunovant Inc5.4M−0.4%$2.1亿1.0%
17IDYA Ideaya Biosciences Inc5.0M+26.9%$1.9亿0.9%
18KNSA Kiniksa Pharmaceuticals Intl2.8M+0.3%$1.8亿0.9%
19ROIV Roivant Sciences Ltd4.7M−3.1%$1.7亿0.8%
20ARWR Arrowhead Pharmaceuticals In2.0M+0.0%$1.6亿0.8%
21IONS Ionis Pharmaceuticals Inc2.0M+0.0%$1.6亿0.8%
22EWTX Edgewise Therapeutics Inc3.7M−43.7%$1.5亿0.8%
23REPL Replimune Group Inc11.0M+0.0%$1.2亿0.6%
24NRIX Nurix Therapeutics Inc4.7M+0.0%$1.1亿0.6%
25STOK Stoke Therapeutics Inc3.3M+0.0%$1.1亿0.5%
26GLUE Monte Rosa Therapeutics Inc4.3M+0.0%$1.1亿0.5%
27IMTX Immatics N.V9.5M−12.9%$9632万0.5%
28DNLI Denali Therapeutics Inc3.7M+0.1%$9605万0.5%
29CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In2.4M+0.0%$8799万0.4%
30DNTH Dianthus Therapeutics Inc852,164+0.0%$8307万0.4%
31GPCR Structure Therapeutics Inc1.4M+0.0%$7688万0.4%
32RAPP Rapport Therapeutics Inc1.5M+0.0%$6447万0.3%
33ALMS Alumis Inc2.0M+0.0%$5663万0.3%
34PRLD Prelude Therapeutics Inc10.1M+0.0%$5396万0.3%
35RLAY Relay Therapeutics Inc2.8M+143.7%$5289万0.3%
36MIRM Mirum Pharmaceuticals Inc445,975+0.0%$5221万0.3%
37BCYC Bicycle Therapeutics Plc10.9M+0.0%$4615万0.2%
38ELVN Enliven Therapeutics Inc905,191+0.0%$4594万0.2%
39CLDX Celldex Therapeutics Inc New1.2M+77.7%$4400万0.2%
40VRDN Viridian Therapeutics Inc2.4M+20.9%$4378万0.2%
41DSGN Design Therapeutics Inc2.7M+3.6%$3876万0.2%
42TRDA Entrada Therapeutics Inc5.1M+0.0%$3734万0.2%
43FTH Faeth Therapeutics Inc1.3M—$3216万0.2%
44AKTS Aktis Oncology Inc996,351+0.0%$3211万0.2%
45NGNE Neurogene Inc991,691+0.0%$3119万0.2%
46JBIO Jade Biosciences Inc1.2M−25.0%$2734万0.1%
47TSHA Taysha Gene Therapies Inc4.0M+0.0%$2727万0.1%
48RCUS Arcus Biosciences Inc844,816+103.3%$2605万0.1%
49IRON Disc Medicine Inc349,657+0.0%$2557万0.1%
50ABSI Absci Corporation2.1M+0.0%$2474万0.1%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。